David Larsen
Stock Analyst at BTIG
(1.99)
# 3,102
Out of 5,124 analysts
93
Total ratings
34.67%
Success rate
-3.2%
Average return
Main Sectors:
Stocks Rated by David Larsen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BTSG BrightSpring Health Services | Maintains: Buy | $41 → $50 | $37.45 | +33.51% | 4 | Dec 23, 2025 | |
| SLP Simulations Plus | Downgrades: Neutral | n/a | $18.23 | - | 4 | Dec 18, 2025 | |
| LFST LifeStance Health Group | Maintains: Buy | $9 → $10 | $7.04 | +42.05% | 2 | Dec 12, 2025 | |
| PIII P3 Health Partners | Suspends: Neutral | n/a | $3.49 | - | 3 | Dec 12, 2025 | |
| AGL agilon health | Suspends: Neutral | n/a | $0.69 | - | 2 | Dec 12, 2025 | |
| HQY HealthEquity | Reiterates: Buy | $130 | $91.61 | +41.91% | 5 | Dec 4, 2025 | |
| VEEV Veeva Systems | Reiterates: Buy | $340 | $223.23 | +52.31% | 4 | Nov 21, 2025 | |
| LFMD LifeMD | Maintains: Buy | $18 → $10 | $3.41 | +193.26% | 4 | Nov 18, 2025 | |
| EVH Evolent Health | Maintains: Buy | $20 → $16 | $4.00 | +300.00% | 7 | Nov 7, 2025 | |
| ASTH Astrana Health | Maintains: Buy | $50 → $45 | $24.81 | +81.38% | 2 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $85 | $32.47 | +161.78% | 2 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $3.56 | +96.63% | 1 | Oct 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $15 | $9.60 | +56.25% | 4 | Sep 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $2.39 | - | 4 | Sep 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $80 | $44.28 | +80.67% | 2 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $28 | $25.68 | +9.03% | 4 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $31 | $21.82 | +42.07% | 3 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $290 → $260 | $225.41 | +15.35% | 2 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $7 | $2.88 | +143.06% | 1 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $7 | $0.88 | +697.45% | 4 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $45.30 | - | 7 | Nov 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $23.71 | +47.62% | 1 | Apr 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $7.00 | - | 3 | Nov 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $4.91 | - | 1 | Jan 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $205.50 | - | 6 | Nov 16, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $170 → $160 | $820.29 | -80.49% | 2 | May 29, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $75.58 | - | 5 | Apr 4, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $90 → $85 | $79.36 | +7.11% | 3 | Feb 9, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $34 → $23 | $2.80 | +721.43% | 1 | Nov 2, 2017 |
BrightSpring Health Services
Dec 23, 2025
Maintains: Buy
Price Target: $41 → $50
Current: $37.45
Upside: +33.51%
Simulations Plus
Dec 18, 2025
Downgrades: Neutral
Price Target: n/a
Current: $18.23
Upside: -
LifeStance Health Group
Dec 12, 2025
Maintains: Buy
Price Target: $9 → $10
Current: $7.04
Upside: +42.05%
P3 Health Partners
Dec 12, 2025
Suspends: Neutral
Price Target: n/a
Current: $3.49
Upside: -
agilon health
Dec 12, 2025
Suspends: Neutral
Price Target: n/a
Current: $0.69
Upside: -
HealthEquity
Dec 4, 2025
Reiterates: Buy
Price Target: $130
Current: $91.61
Upside: +41.91%
Veeva Systems
Nov 21, 2025
Reiterates: Buy
Price Target: $340
Current: $223.23
Upside: +52.31%
LifeMD
Nov 18, 2025
Maintains: Buy
Price Target: $18 → $10
Current: $3.41
Upside: +193.26%
Evolent Health
Nov 7, 2025
Maintains: Buy
Price Target: $20 → $16
Current: $4.00
Upside: +300.00%
Astrana Health
Nov 7, 2025
Maintains: Buy
Price Target: $50 → $45
Current: $24.81
Upside: +81.38%
Nov 4, 2025
Reiterates: Buy
Price Target: $85
Current: $32.47
Upside: +161.78%
Oct 21, 2025
Reiterates: Buy
Price Target: $7
Current: $3.56
Upside: +96.63%
Sep 18, 2025
Maintains: Buy
Price Target: $10 → $15
Current: $9.60
Upside: +56.25%
Sep 5, 2025
Reiterates: Neutral
Price Target: n/a
Current: $2.39
Upside: -
Jun 2, 2025
Upgrades: Buy
Price Target: $80
Current: $44.28
Upside: +80.67%
Mar 31, 2025
Upgrades: Buy
Price Target: $28
Current: $25.68
Upside: +9.03%
Nov 11, 2024
Maintains: Buy
Price Target: $30 → $31
Current: $21.82
Upside: +42.07%
Nov 1, 2024
Maintains: Buy
Price Target: $290 → $260
Current: $225.41
Upside: +15.35%
Sep 17, 2024
Initiates: Buy
Price Target: $7
Current: $2.88
Upside: +143.06%
May 9, 2024
Maintains: Buy
Price Target: $11 → $7
Current: $0.88
Upside: +697.45%
Nov 3, 2023
Downgrades: Neutral
Price Target: n/a
Current: $45.30
Upside: -
Apr 28, 2022
Initiates: Buy
Price Target: $35
Current: $23.71
Upside: +47.62%
Nov 22, 2021
Downgrades: Neutral
Price Target: n/a
Current: $7.00
Upside: -
Jan 7, 2021
Initiates: Neutral
Price Target: n/a
Current: $4.91
Upside: -
Nov 16, 2018
Downgrades: Market Perform
Price Target: n/a
Current: $205.50
Upside: -
May 29, 2018
Maintains: Market Perform
Price Target: $170 → $160
Current: $820.29
Upside: -80.49%
Apr 4, 2018
Upgrades: Outperform
Price Target: n/a
Current: $75.58
Upside: -
Feb 9, 2018
Maintains: Outperform
Price Target: $90 → $85
Current: $79.36
Upside: +7.11%
Nov 2, 2017
Maintains: Market Perform
Price Target: $34 → $23
Current: $2.80
Upside: +721.43%